Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/23238
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDean, C.-
dc.contributor.authorBockmann, M.-
dc.contributor.authorHopwood, J.-
dc.contributor.authorBrooks, D.-
dc.contributor.authorMeikle, P.-
dc.date.issued2006-
dc.identifier.citationClinical Chemistry (Washington, DC): international journal of molecular diagnostics and laboratory medicine, 2006; 52(4):643-649-
dc.identifier.issn0009-9147-
dc.identifier.issn1530-8561-
dc.identifier.urihttp://hdl.handle.net/2440/23238-
dc.descriptionCopyright © 2006 American Association for Clinical Chemistry, Inc.-
dc.description.abstract<h4>Background</h4>Mucopolysaccharidosis type II (MPS II) is a lysosomal storage disorder related to a deficiency in the enzyme iduronate-2-sulfatase (IDS). Clinical trials of enzyme replacement therapy are in progress, but effective treatment will require screening assays to enable early detection and diagnosis of MPS II. Our study evaluated the diagnostic accuracy of IDS protein and enzyme activity measurements in dried blood spots and plasma.<h4>Methods</h4>We collected dried-blood-spot and plasma samples from unaffected control individuals and from MPS II patients. We measured IDS protein concentration with a 2-step time-delayed dissociation-enhanced lanthanide fluorescence immunoassay. To measure enzyme activity, we immobilized anti-IDS antibody on microtiter plates to capture the enzyme and measured its activity with the fluorogenic substrate 4-methylumbelliferyl sulfate.<h4>Results</h4>Dried-blood-spot samples from MPS II patients showed an almost total absence of IDS activity (0-0.075 micromol x h(-1) x L(-1)) compared with control blood spots (0.5-4.7 micromol x h(-1) x L(-1)) and control plasma (0.17-8.1 micromol x h(-1) x L(-1)). A dried-blood-spot sample from only 1 of 12 MPS II patients had detectable concentrations of IDS protein (24.8 microg/L), but no IDS protein was detected in plasma from MPS II patients. Ranges for IDS protein in control samples were 25.8-153 microg/L for blood spots and 22.8-349.4 microg/L for plasma.<h4>Conclusion</h4>Measurement of the IDS protein concentration and enzyme activity (as measured by a simple fluorogenic assay with an immune capture technique) enables identification of the majority of MPS II patient samples from both dried blood spots and plasma samples.-
dc.description.statementofresponsibilityCaroline J. Dean, Michelle R. Bockmann, John J. Hopwood, Doug A. Brooks and Peter J. Meikle-
dc.language.isoen-
dc.publisherAmer Assoc Clinical Chemistry-
dc.subjectCHO Cells-
dc.subjectPlasma-
dc.subjectAnimals-
dc.subjectHumans-
dc.subjectCricetulus-
dc.subjectMucopolysaccharidosis II-
dc.subjectHymecromone-
dc.subjectIduronate Sulfatase-
dc.subjectRecombinant Proteins-
dc.subjectIndicators and Reagents-
dc.subjectImmunoassay-
dc.subjectBlood Specimen Collection-
dc.subjectCalibration-
dc.subjectFluorometry-
dc.subjectAdolescent-
dc.subjectAdult-
dc.subjectMiddle Aged-
dc.subjectChild-
dc.subjectChild, Preschool-
dc.subjectInfant-
dc.subjectCricetinae-
dc.subjectClinical Enzyme Tests-
dc.titleDetection of mucopolysaccharidosis type II by measurement of iduronate-2-sulfatase in dried blood spots and plasma samples-
dc.typeJournal article-
dc.identifier.doi10.1373/clinchem.2005.061838-
pubs.publication-statusPublished-
dc.identifier.orcidBockmann, M. [0000-0001-8050-0993]-
dc.identifier.orcidBrooks, D. [0000-0001-9098-3626]-
Appears in Collections:Aurora harvest 6
Paediatrics publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.